§ Mr. KidneyTo ask the Secretary of State for Health what evaluation he has made of the clinical trials regarding the use of Aricept in treating patients suffering from Alzheimer's disease. [67993]
§ Mr. HuttonInformation regarding the use of Aricept in patients suffering from Alzheimer's disease from clinical trials has been considered by the Medicines Control Agency.
The Standing Medical Advisory Committee, which advises health ministers, also considered available evidence from clinical trials and has reflected these in the clinical statement issued in April 1998.
§ Mr. KidneyTo ask the Secretary of State for Health under what circumstances the drug Aricept is currently available by prescription for the treatment of Alzheimer's disease. [67992]
§ Mr. DenhamAricept (donepezil) is licensed in the United Kingdom for the treatment of mild to moderate Alzheimer's disease, and can be prescribed by doctors on the National Health Service. The Standing Medical Advisory Committee has recommended that this treatment should be initiated only following a specialist assessment.